Abstract: A pedal with anti-collision detection is installed on the rear of a vehicle. The pedal includes a pedal body and a radar device, with an insertion portion extending from the rear lateral side of the pedal body. Arc ribs are arranged from a rear lateral side of the pedal body toward a front lateral side of the pedal body at intervals, and straight ribs extend from the rear lateral side toward the front lateral side in a radial arrangement. The arc ribs and the straight ribs are interlaced, forming reinforcement spaces therebetween. An installation space is formed on an inner side of the front lateral side toward the rear lateral side for receiving the radar device. Each reinforcement space contains a reinforcement structure, thereby strengthening the structural strength of the pedal for protecting the radar device.

Abstract: An intellectual quality management method is disclosed. A heatmap risk interface is created according to the required data and the parameter configuration which are calculated using a time dependent risk priority number (RPN) equation. An intellectual audit scheduling algorithm is defined via the heatmap risk interface to automatically generate at least one audit plan. An audit program corresponding to the audit plan is performed and a plurality of problem points are selected. Intellectual root cause category recommendation is performed to the questions points. intellectual corrective actions and preventive action recommendations are performed to the problem points according to the intellectual root cause category recommendation to obtain at least one optimum corrective action and at least one preventive action.

Abstract: A method for labeling object of operating system is adapted to a target object of a target operating system, wherein the target object has a target attribute. The method comprises: generating a default label by a labeling tool according to the target attribute; obtaining a reference object of a reference operating system, wherein the reference object has a reference attribute and a reference label; comparing whether the target attribute and the reference attribute are identical and generating a comparison result; and labeling the target object with the default label, the reference label, or one of a plurality of candidate labels according to the comparison result and a type of the target object.

Abstract: A portable blowing device includes at least one support rod and a plurality of blades. The support rod comprises an upper rod portion, a lower rod portion, and a rotating ring that is located between the upper rod portion and the lower rod portion. A hook is disposed on the top end of the upper rod portion, and pluralities of first fixed portions are disposed on the outer surface of the rotating ring. Each blade has a first connection portion for connecting to the corresponding first fixed portion of the rotating ring. When the blowing device is activated, the rotation of blades generates the airflow to blow user or the clothes hung on a support frame.

Abstract: The present disclosure relates to pharmaceutical composition for the treatment of joint pain. The composition contains a lipid mixture comprising one or more phospholipids; and an effective amount of a therapeutic agent or a pharmaceutically acceptable salt thereof, where the total amount of phospholipids in said composition is about 20 mM to about 150 mM, optionally 70 mM to 110 mM. Also provided is the use of the pharmaceutical composition in the treatment of joint pain by articular injection.

Abstract: Provided are methods of treating joint pain, comprising administering to a subject in need of joint pain treatment an effective amount of a pharmaceutical composition comprising a lipid mixture comprising one or more lipids; and an effective amount of an intra-articular steroid or a pharmaceutically acceptable salt thereof, wherein the therapeutic efficacy of the intra-articular steroid is sustained but the side effects associated with the intra-articular steroid are reduced.

Abstract: The present invention provides methods of treating arthritis. A sustained release composition comprising liposomes and one or more therapeutic agent or a pharmaceutically acceptable salt thereof is administered to a subject in need thereof. The liposomes may be in an aqueous suspension. The sustained release composition can be administered intraarticularly.

Abstract: The present invention provides methods of treating arthritis. A sustained release composition comprising liposomes and one or more therapeutic agent or a pharmaceutically acceptable salt thereof is administered to a subject in need thereof. The liposomes may be in an aqueous suspension. The sustained release composition can be administered intraarticularly.

Abstract: An ophthalmic drug delivery system that contains phospholipid and cholesterol for prolonging drug lifetime in the eyes.

Abstract: The present invention provides methods of treating arthritis. A sustained release composition comprising liposomes and one or more therapeutic agent or a pharmaceutically acceptable salt thereof is administered to a subject in need thereof. The liposomes may be in an aqueous suspension. The sustained release composition can be administered intraarticularly.

Abstract: The present invention provides methods of treating arthritis. A sustained release composition comprising liposomes and one or more therapeutic agent or a pharmaceutically acceptable salt thereof is administered to a subject in need thereof. The liposomes may be in an aqueous suspension. The sustained release composition can be administered intraarticularly.

Abstract: An ophthalmic drug delivery system that contains phospholipid and cholesterol for prolonging drug lifetime in the eyes.

Abstract: A portable blowing device includes at least one support rod and a plurality of blades. The support rod comprises an upper rod portion, a lower rod portion, and a rotating ring that is located between the upper rod portion and the lower rod portion. A hook is disposed on the top end of the upper rod portion, and pluralities of first fixed portions are disposed on the outer surface of the rotating ring. Each blade has a first connection portion for connecting to the corresponding first fixed portion of the rotating ring. When the blowing device is activated, the rotation of blades generates the airflow to blow user or the clothes hung on a support frame.

Abstract: The present invention provides methods of treating arthritis. A sustained release composition comprising liposomes and one or more therapeutic agent or a pharmaceutically acceptable salt thereof is administered to a subject in need thereof. The liposomes may be in an aqueous suspension. The sustained release composition can be administered intraarticularly.

Abstract: The present invention relates to pharmaceutical compositions comprising a combination of a lipid cake mixture comprising one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid, derivative thereof, a pharmaceutically acceptable salt thereof or a prodrug thereof, wherein the total amount of the phospholipid in the said composition is about 0.1 umol to less than about 2.5 umol per 50 ul of pharmaceutical composition and the side effects of the ocular steroid are reduced. The pharmaceutical composition is preferably administered by ocular route to treat ophthalmic diseases.

Abstract: The present invention provides methods of treating arthritis. A sustained release composition comprising liposomes and one or more therapeutic agent or a pharmaceutically acceptable salt thereof is administered to a subject in need thereof. The liposomes may be in an aqueous suspension. The sustained release composition can be administered intraarticularly.

Abstract: The present invention relates to pharmaceutical compositions comprising a combination of a lipid cake mixture comprising one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid, derivative thereof, a pharmaceutically acceptable salt thereof or a prodrug thereof, wherein the total amount of the phospholipid in the said composition is about 0.1 umol to less than about 2.5 umol per 50 ul of pharmaceutical composition and the side effects of the ocular steroid are reduced. The pharmaceutical composition is preferably administered by ocular route to treat ophthalmic diseases.

Abstract: The present invention relates to pharmaceutical compositions comprising a combination of a lipid cake mixture comprising one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid, derivative thereof a pharmaceutically acceptable salt thereof or a prodrug thereof, wherein the total amount of the phospholipid in the said composition is about 0.1 umol to less than about 2.5 umol per 50 ul of pharmaceutical composition and the side effects of the ocular steroid are reduced. The pharmaceutical composition is preferably administered by ocular route to treat ophthalmic diseases.

Abstract: System and method for array antenna failure detection and antenna self-correction are introduced. In the array antenna failure detection and antenna self-correction system, a signal analyzer is employed to perform gain analysis so as to perform gain attenuation/compensation, and a DC offset generator is employed to generate a set of known offset amounts which are added to signals, so that, at the receiving end, a phase offset amount can be derived based on comparisons with the original signal, and antenna correction can then be performed accordingly. In this way, computational complexity of the system can be reduced, and the speed of antenna correction can be increased.

Abstract: The present invention relates to pharmaceutical compositions comprising a combination of a lipid cake mixture comprising one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid, derivative thereof, a pharmaceutically acceptable salt thereof or a prodrug thereof, wherein the total amount of the phospholipid in the said composition is about 0.1 umol to less than about 2.5 umol per 50 ul of pharmaceutical composition and the side effects of the ocular steroid are reduced. The pharmaceutical composition is preferably administered by ocular route to treat ophthalmic diseases.